MicroRNA

May 9, 2017May 9, 2017

MicroRNA Levels Could Help Distinguish Malignant Mesothelioma from Lung Cancer, Study Reports

News

Analyzing the levels of microRNA (miRNA)-130a in cells collected from pleural effusions, a condition in which fluid accumulates between the thin membranes surrounding the lungs, may help distinguish malignant pleural ... Read more

March 29, 2017March 29, 2017

Blood Levels of MicroRNA May Be Biomarker for Early Diagnosis of Malignant Mesothelioma

News

A small RNA molecule called miR-132-3p was found to be downregulated in blood samples of mesothelioma patients. In combination with other biomarkers, this microRNA could improve the early detection and ... Read more

October 13, 2016

Scientists Find New Mechanism that May Help Develop Therapies Targeting Mesothelioma

News

Researchers have identified a novel mechanism that stimulates the death of malignant pleural mesothelioma (MPM) cells, providing potential therapeutic targets for the treatment of this aggressive disease. The study, “MicroRNA-302b ... Read more

October 5, 2016

Rosetta Receives 2 Patent Allowances, 1 for Mesothelioma Diagnostic

News

Rosetta Genomics, a company that develops microRNA-based diagnostics, has added two new patent allowances to its intellectual property. A patent allowance is issued by a regulatory entity (U.S. Patent and ... Read more